A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes. (Q53661005)
Jump to navigation
Jump to search
scientific article published in February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes. |
scientific article published in February 2006 |
Statements
A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes. (English)
Claudia Haas
Maria Lulei
Philippe Fournier
Annette Arnold
Volker Schirrmacher
1 February 2006
118
3
658-667
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference